tiprankstipranks
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market
Want to see AU:IXC full AI Analyst Report?

Invex Therapeutics Ltd. (IXC) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Invex Therapeutics Ltd.’s (IXC) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Invex Therapeutics Ltd. is a Sell.
Invex Therapeutics Ltd.’s (IXC) 20-Day exponential moving average is 0.10, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Buy.
Invex Therapeutics Ltd.’s (IXC) 50-Day exponential moving average is 0.11, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Buy.

Invex Therapeutics Ltd. (IXC) Pivot Points

Jul 23, 2026, 04:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.09
0.10
0.10
0.11
0.11
0.11
0.11
Fibonacci
0.10
0.10
0.10
0.11
0.11
0.11
0.11
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Invex Therapeutics Ltd. (IXC) Moving Averages

Jul 23, 2026, 04:03 PM
Period
Simple
Exponential
MA5
0.11Buy
0.11Buy
MA10
0.10Buy
0.11Buy
MA20
0.10Buy
0.10Buy
MA50
0.11Buy
0.11Buy
MA100
0.11Buy
0.11Buy
MA200
0.12Buy
0.11Buy
Invex Therapeutics Ltd.’s (IXC) 10-Day exponential moving average is 0.11, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Buy.
Invex Therapeutics Ltd.’s (IXC) 100-Day exponential moving average is 0.11, while Invex Therapeutics Ltd.’s (IXC) share price is AU$0.12, making it a Buy.
Invex Therapeutics Ltd.’s (IXC) stock price is AU$0.12 and Invex Therapeutics Ltd.’s (IXC) 50-day simple moving average is 0.11, creating a Buy signal.
Invex Therapeutics Ltd.’s (IXC) stock price is AU$0.12 and Invex Therapeutics Ltd.’s (IXC) 100-day simple moving average is 0.11, creating a Buy signal.
Invex Therapeutics Ltd.’s (IXC) stock price is AU$0.12 and Invex Therapeutics Ltd.’s (IXC) 200-day simple moving average is 0.12, creating a Buy signal.

Invex Therapeutics Ltd. (IXC) Technical Indicators

Jul 23, 2026, 04:03 PM
Name
Value
Implied Action
RSI (14)
62.93
Neutral
STOCH (9,6)
66.67
Neutral
STOCHRSI (14)
76.67
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
27.82
Neutral
Williams %R
25.00
Sell
CCI (14)
186.35
Sell
ATR (14)
0.01
-
Ultimate Oscillator
24.67
Sell
ROC
20.00
Buy
Invex Therapeutics Ltd.’s (IXC) Relative Strength Index (RSI) is 62.93, creating a Neutral signal.
Invex Therapeutics Ltd.’s (IXC) Trend Strength Indicator (ADX) is 27.82, creating a Neutral signal.
Invex Therapeutics Ltd.’s (IXC) Commodity Channel Index (CCI) is 186.35, creating a Sell signal.
Invex Therapeutics Ltd.’s (IXC) Price Rate of Change (ROC) is 20.00, creating a Buy signal.

FAQ

Is IXC a Buy, Hold, or Sell?
Based on IXC’s technical indicators, IXC is a Buy.
    What is IXC’s RSI (14)?
    IXC’s RSI (14) is 62.93, which suggests IXC is a Neutral.
      What is IXC’s MACD?
      IXC’s MACD is >-0.01, which suggests IXC is a Sell.
        What is IXC’s 5-day moving average?
        IXC’s 5-day moving average is 0.11, which suggests IXC is a Buy.
          What is IXC’s 20-day moving average?
          IXC 20-day moving average is 0.10, which suggests IXC is a Buy.
            What is IXC’s 50-day moving average?
            IXC’s 50-day moving average is 0.11, which suggests IXC is a Buy.
              What is IXC’s 200-day moving average?
              IXC’s 200-day moving average is 0.12, which suggests IXC is a Buy.
                What is IXC’s Williams % R (14)?
                IXC’s Williams % R (14) is 25.00, which suggests IXC is a Sell.
                  What is IXC’s CCI (14)?
                  IXC’s CCI (14) is 186.35, which suggests IXC is a Sell.
                    What is the share price of Invex Therapeutics Ltd.?